Alfred Reszka BS, PhD

Alfred (Al) Reszka is Executive Director and Head of Global Competitive Intelligence at MSD. Al and his team work with clients in Strategy, Marketing, R&D and Manufacturing across a variety of business functions requiring scientific, medical and business intelligence. The group functions as a strategic consultancy within Merck that leverages intelligence to impact strategy and the top and bottom lines. Roles and responsibilities include consulting in product and pipeline intelligence across all therapeutic areas, portfolio prioritization, strategic benchmarking and strategy development, product surveillance and defense, mature product strategies, emerging markets, licensing, business development, M&A and the Merck Library.

Al joined Merck in 1997, and prior to joining the Global Competitive Intelligence group in 2007, he was Senior Research Fellow in Bone Basic Research in R&D, where he led research that elucidated the mechanism of action of alendronate (FOSAMAX) and where he led drug discovery efforts for a variety of osteoporosis programs. Al earned his Ph.D. in Cell Biology at the University of Illinois, Urbana-Champaign in 1992 and subsequently conducted postdoctoral research on MAP Kinase (ERK1/2) mediated signal transduction with Nobel Laureates, Edmund Fischer and Edwin Krebs at the University of Washington in Seattle.